Alt-Bionics
Develops affordable, AI-enhanced bionic hands for upper-limb amputees and high-performance end effectors for humanoid robotics using 3D printing.
- CEO / Founder
- Ryan Saavedra
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $2.45M
- Latest Round
- Seed+ - $1.25M - June 2024
- Key Investors
- Norfolk State University Innovation Center; City of San Antonio (SAMMI Fund); Alamo Angels; VelocityTX; Capital Factory; Austin Technology Incubator
Technology & Products
Key Products
Alt-Bionics develops high-performance, durable, and cost-effective bionic hands for both amputees and humanoid robots. Their flagship product is the Genesis Hand, a myoelectric prosthetic bionic hand designed to translate muscle signals into intuitive movement.
Technological Advantage
Cost reduction via 3D printing (MJF) allows for insurance-compatible pricing and accessibility in developing markets.
Differentiation
Value Proposition
Reduces cost of bionic prosthetics to make them accessible/affordable for below-elbow amputees while maintaining high performance (6 degrees of freedom).
How They Differentiate
Focus on affordability and accessibility through 3D printing cost-efficiencies compared to traditional bionic hands.
Market & Competition
Target Customers
Upper-limb amputees (via NGOs, insurance, direct), humanoid robotics firms
Industry Verticals
Medical; Robotics
Competitors
Össur hf, Touch Bionics Inc, Open Bionics
Growth & Milestones
Growth Metrics
1.2M+ social media followers; Customer Acquisition Cost (CAC) <$10; 10 employees; Target product price point of $5,000
Major Milestones
Genesis Hand production via 3D printing (2024); Expansion to humanoid robotics; Series A planned post-2021
Notable Customers
Nvidia